Fukuda Denshi Co., Ltd.

Tokyo Stock Exchange 6960.T

Fukuda Denshi Co., Ltd. EPS (Diluted) for the year ending March 31, 2024: USD 4.11

Fukuda Denshi Co., Ltd. EPS (Diluted) is USD 4.11 for the year ending March 31, 2024, a -4.35% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Fukuda Denshi Co., Ltd. EPS (Diluted) for the year ending March 31, 2023 was USD 4.30, a -2.39% change year over year.
Fukuda Denshi Co., Ltd. EPS (Diluted) for the year ending March 31, 2022 was USD 4.40, a 0.24% change year over year.
Fukuda Denshi Co., Ltd. EPS (Diluted) for the year ending March 31, 2021 was USD 4.39, a 49.31% change year over year.
Fukuda Denshi Co., Ltd. EPS (Diluted) for the year ending March 31, 2020 was USD 2.94, a 3.71% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Tokyo Stock Exchange: 6960.T

Fukuda Denshi Co., Ltd.

CEO	Mr. Kotaro Fukuda
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	2-35-8 Hongo
Employees	3,443
Sector	Healthcare
Industries Medical Instruments Hardware & Electronics Telehealth

Description

Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.

Key trends

Past 5 years